Articles tagged with Drug Therapy
A new study highlights the need for a shift in mental health provision based on public views and individual perspectives. Mental health professionals should adapt their practice to acknowledge patients' beliefs and preferences, rather than relying on assumed assumptions.
Researchers discovered that malaria parasites adjust their reproduction strategy based on host conditions, opting to invest more in reproduction when conditions are favorable and prioritizing survival during adverse times. This finding could inform the development of new treatments by prompting parasites to spread more easily.
Researchers have created an oral formulation of semaglutide, a successful type 2 diabetes therapy, that can be more readily absorbed in the stomach. This development has the potential to improve treatment flexibility and patient adherence to T2D treatment programs, offering patients a less invasive route of administration.
Researchers at MD Anderson Cancer Center report high response rates of 90% among frontline-treated patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). The study, led by Naveen Pemmaraju, presents a novel targeted therapy targeting CD-123, a cell surface receptor expressed in BPDCN and other hematologic malignancies.
Indiana University researchers observed nanoparticles rotate differently when binding to receptors, indicating varying levels of cellular binding strength. This discovery could lead to more effective drug treatments and improved immunotherapy.
A new study found that personalized medicine technique reduced treatment times by up to 6 weeks, with 21 patients remaining virus-free and no significant loss of efficacy. The results have the potential to save $10 billion annually in healthcare costs.
Researchers have identified a drug that inhibits the signalling pathway of enzyme MEKK3, a process contributing to cerebral cavernous malformations (CCM), a leading cause of stroke in young people. A suitable candidate, Ponatinib, is currently used to treat cancer patients and may offer a non-invasive treatment option.
Researchers at The Feinstein Institute for Medical Research used genetic tests to predict patient response to antipsychotic medication in schizophrenia patients. They found higher polygenic risk scores were associated with reduced effectiveness of conventional treatment.
A new study reveals that states expanding Medicaid from 2011 to 2017 experienced a significant 27% increase in prescriptions for hormonal therapy medications compared to non-expansion states. This rise was attributed to increased access for previously uninsured women who required long-term treatment with these life-saving drugs.
Researchers at Duke-NUS Medical School and Singapore General Hospital develop a fully human system to cultivate skin cells for grafting, eliminating the need for animal-derived products. This breakthrough method uses specific laminin proteins to support the growth of human keratinocytes in the laboratory.
A small study found that rose geranium oil spray in sesame oil base helped reduce the severity of nasal vestibulitis symptoms, which are common side effects of chemotherapy. The oil was used by 20 women on chemotherapy, with most reporting moderate to substantial benefits.
A small observational study suggests that rose geranium oil spray can help alleviate nasal vestibulitis, a common and painful condition caused by cancer drug treatment. The study found that 55% of participants experienced moderate benefit from using the oil, with some reporting complete symptom resolution.
A phase II clinical trial found that sparsentan significantly reduces proteinuria by 45% in patients with focal segmental glomerulosclerosis (FSGS), a rare kidney disorder. The study also suggests potential implications for other kidney diseases characterized by proteinuria.
The HOBOE-2 trial found that zoledronic acid plus letrozole improved disease-free survival in premenopausal women with HR+ early breast cancer, with a 5-year DFS probability of 0.93 compared to 0.85 for tamoxifen. The combination treatment reduced breast cancer recurrence and mortality by nearly half.
A new study found that factors such as extraversion, openness, independence, and social support positively impact mental wellbeing in young adults with kidney failure. Higher medication adherence was linked to living with parents, conscientiousness, and physician access satisfaction.
A survey found that Americans wish doctors discuss their mental, spiritual, and lifestyle factors with them. Most patients want to talk about why they're healthy, non-drug treatments, and factors influencing overall well-being.
Scientists at Northwestern University have created a bioelectronic medicine that uses electrical stimulation to accelerate nerve regeneration and improve muscle strength in rats. The device, made of biodegradable materials, is powered wirelessly and operates for up to two weeks before naturally absorbing into the body.
A large multi-ethnic study found that high circulating levels of an inflammatory marker are linked to long-term decline in kidney function. The study suggests a novel marker, soluble TNFR-1, is strongly related to kidney function decline over time.
Researchers discuss historical and current evidence-based approaches to stimulating female sexual desire, highlighting the role of dopamine and music in enhancing pleasure. The study aims to improve healthcare providers' understanding of women's sexual health, particularly those affected by hypoactive sexual desire disorder.
A study published in eBioMedicine found that the absence of four particular genes in the Leishmania infantum parasite makes it less susceptible to miltefosine, an oral drug used to treat visceral leishmaniasis. This discovery could lead to a new prognostic test to predict treatment outcomes and tailor medicines accordingly.
Researchers at Mayo Clinic developed a new genetics-based prognostic tool for myelodysplastic syndrome, which integrates genetic and clinical information to provide more accurate predictions. The tool identifies favorable gene mutations, such as SF3B1, and unfavorable mutations, like ASXL1 and RUNX1, to guide treatment decisions.
The ASBMR Fracture Prevention Initiative Coalition releases new clinical recommendations to tackle the public health crisis of osteoporosis and its debilitating hip and spine fractures. The guidelines aim to increase diagnosis and treatment of high-risk individuals, particularly those over 65 with a history of hip or vertebral fractures.
A large-scale international study published in PLOS Medicine found that a new medication called Nilvadipine showed promise in slowing the progression of mild and moderate Alzheimer's disease. However, the overall group of patients did not benefit from the treatment. Further research is needed to explore its potential.
A new study reveals that black women are more likely to skip hormone therapy treatments for breast cancer, with barriers including cost, side effects, and difficulty adhering to treatment plans. The study highlights the need for culturally competent behavioral interventions to improve outcomes for all women with breast cancer.
Crowdfunding sites have seen a surge in UK cancer-related appeals, with £8m raised since 2012. Critics argue that these platforms are not adequately vetting appeals, potentially leading to patients being exploited by unproven treatments.
A large study found that commencing treatment for sleep apnea after a stroke significantly improves speech impairment, neurological symptoms, and physical functioning. The diagnosis and treatment of sleep apnea with CPAP therapy provides benefits greater than the FDA-approved drug treatment for stroke.
The American College of Medical Genetics and Genomics emphasizes the need for affordable treatment options for rare and ultra-rare diseases. Key recommendations include preventing abuses of the Orphan Drug Act and aligning drug packaging with dosing recommendations to reduce waste. The organization urges policymakers to develop simple,...
Researchers have discovered that neurons themselves trigger the immune system response in Rasmussen's encephalitis, leading to synaptic damage. By blocking this signalling pathway, they may be able to develop new treatments for the disease.
The BASKET-SMALL 2 trial found that a removable balloon is as good as a permanent stent for opening small blocked arteries, with no significant differences in major adverse cardiac events. The study showed improved outcomes without the need for prolonged treatment with anticlotting medicines.
The 2018 Fourth Universal Definition of Myocardial Infarction provides clarity on diagnosing a heart attack, distinguishing between myocardial infarction and myocardial injury. Elevated troponin levels are not sufficient for diagnosis, and oxygen shortage detection via electrocardiogram is crucial.
A randomized clinical trial found that a pill containing low doses of three antihypertensive drugs resulted in a greater percentage of patients achieving their target blood pressure goal. The study included 700 patients in Sri Lanka who were not receiving treatment or taking one medication.
Neurologist Camilo R. Gomez argues that the effect of time on ischemic stroke outcomes varies greatly among patients, with collateral circulation playing a critical role in determining treatment efficacy. He proposes a new approach to stroke care, taking into account individual patient variability and blood circulation patterns.
A KAIST research team has developed a flexible drug delivery device with controlled release, blurring the path toward theragnosis. The device boasts fewer side effects and uniform therapeutic results compared to oral ingestion, making it suitable for smart contact lenses and brain disease treatments.
A review suggests that cannabidiol, a compound in cannabis, may have modest efficacy in treating severe epilepsy, particularly in children. However, more rigorous clinical trials are necessary to fully understand its potential and minimize side effects.
A new study from McGill University Health Centre reveals that a four-month rifampin treatment is as effective as nine months of isoniazid in preventing tuberculosis, with significantly fewer side effects. The treatment was also more acceptable to patients, particularly those with liver toxicity.
A Rutgers-led team of scientists has identified two molecules that protect nerve cells after traumatic brain injury and could lead to new treatments. The study found that speeding the breakdown of guanine protects neurons from injury and retains brain functioning.
Researchers identified a new compound called MPS that is over 100 times more potent than the existing drug ethosuximide in reducing neurodegeneration in nematode worms. This discovery may enable novel treatments for human neurodegenerative diseases.
Research found trials supporting drugs granted 'breakthrough' status often lacked randomization and control groups, enrolling small patient numbers. This suggests a lack of robust evidence to support the use of these therapies for serious or life-threatening conditions.
A new study published in the Journal of Neuromuscular Diseases found that early treatment with nusinersen can improve motor function in babies with SMA type 1. The research suggests that early diagnosis and initiation of treatment are crucial for patients with infantile-onset spinal muscular atrophy.
Researchers found that microorganisms within Siberian plants have medicinal and antimicrobial properties, potentially leading to the development of new drugs for serious diseases. The study's authors believe these properties can also be used to stimulate plant growth or protect them from diseases.
The new guidelines will dramatically increase the number of people with hypertension, especially in China, where over half of those aged 45-75 years will be considered hypertensive. This could lead to a significant increase in treatment numbers, with up to 130 million untreated patients in China.
A team of UMBC researchers has developed a novel approach to making therapeutic proteins available at the point of care, enabling faster drug development and more personalized medicines. The portable system, about the size of a suitcase, allows for rapid production without relying on manufacturing facilities or transport.
Researchers developed a personalized Therapeutic Intervention Fingerprint (pTIF) to predict the effectiveness of targeting specific biological factors for controlling neurological disease progression. This technique can categorize patients with their unique physiological needs, leading to more effective and tailored treatments.
A large population study from Denmark found no causal association between assisted reproduction treatment and increased risk of ovarian cancer. Female infertility, rather than ovarian stimulation, was associated with an increased risk of ovarian cancer.
A Vanderbilt University Medical Center study found that deep brain stimulation (DBS) therapy can slow the progression of tremor in early-stage Parkinson's disease patients. DBS applied in early-stage Parkinson's disease may slow the progression of tremor, a finding that suggests potential for new treatment options.
Researchers tested a new approach to caring for people with multiple long-term conditions, which aimed to improve health-related quality of life and patient experience. The '3D' approach simplified complex drug treatment and considered mental health, but showed no improvement in quality of life, challenging current UK guidelines.
A study presented at the SNMMI Annual Meeting found that early treatment of advanced prostate cancer with lutetium-177 radioligand therapy can significantly prolong life, with a median overall survival of 27 months. Patients who received first-line therapy also had the longest survival rates.
PharmaMar and Chugai agree on an early termination of their license agreement for Zepsyre in Japan, allowing PharmaMar to regain rights to the compound. PharmaMar will receive €3,000,000 from Chugai and can now pursue new partnerships for the drug.
A major study found that medications used to treat diabetes in adults are not effective on youth. The disease is progressing rapidly in young people due to the growing obesity epidemic.
Researchers have developed a novel nuclear medicine probe that can detect synaptic density loss in the brain, a key biomarker for neurodegenerative diseases like Alzheimer's. The probe, using positron emission tomography (PET) imaging, has high imaging characteristics and is suitable for clinical trials and commercialization.
A new study from UT Southwestern researchers highlights the importance of diagnosing and treating stress urinary incontinence in men, who often wait years before seeking help. The study recommends a standing cough test as a routine part of male patients' physicals to accurately diagnose and treat this condition.
A study by Daniel Casasanto at Cornell University reveals that left-handed individuals' emotions are housed in the right side of their brains, contradicting traditional models. This suggests a revised approach to treating anxiety and depression, with strong left-handers potentially benefiting from an opposite treatment.
AcuraStem has been awarded a $3.7 million SBIR grant to continue research on a small molecule therapeutic for ALS, utilizing induced motor neuron cellular models and precision platform iNeuroRx°. The grant supports the development of AS2015, targeting expansion repeats in the C9ORF72 gene.
A large trial found no significant difference in long-term smoking abstinence between nicotine preloading and standard therapy, as the beneficial effect may have been masked by a concurrent reduction in varenicline use. However, if overcome, nicotine preloading could lead to increased long-term abstinence rates.
Researchers developed a refillable, implantable device called Therepi that can deliver drugs and therapies directly to diseased tissue. The device increases heart function for more than four weeks when stem cells are repeatedly delivered.
A new study found that only half of migraine patients referred for behavioral treatment made an appointment, citing lack of time, cost concerns, and skepticism as barriers. Despite being first-line, safe, and effective treatments, many patients are not accessing these therapies due to perceived barriers.
IDMC recommends continuing Zepsyre® (lurbinectedin, PM1183) Phase III trial in small-cell lung cancer patients. The pivotal trial assesses the efficacy of PM1183 in combination with doxorubicin compared to standard treatments.
A novel mechanism of action has been identified for the treatment of inflammatory bowel disease, showing promise for a new therapeutic approach. The study discovered that an orally active small molecule, ER-464195-01, suppresses leukocyte adhesion by binding to calreticulin and inhibiting integrin activation.
The article highlights significant flaws in the design, implementation, and analysis of pharmacogenetic tests for treating major depressive disorder (MDD) and related psychiatric conditions. The researchers argue that these tests are not supported by robust evidence and may provide misleading information.
A cancer patient with advanced ovarian cancer responded well to treatment with hydroxychloroquine and quinacrine, initially prescribed for an autoimmune disease. The case report suggests that repurposing antimalarial drugs may improve cancer outcomes.